Showing results (251-260 of 309) with videos related to
Sort By:
Pageof 31
British Journal of Haematology|December 24, 1997
Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignanciesV Snell, K Clodi, S Zhao, et al.British Journal of Haematology|March 22, 2001
Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplificationK Pachmann, S Zhao, T Schenk, et al.Leukemia|May 21, 1998
Multilineage involvement of Philadelphia chromosome positive acute lymphoblastic leukemiaT M Schenk, A Keyhani, S Bottcher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogeneticsS M Kornblau, P F Thall, Z Estrov, et al.Cancer Research|May 1, 1984
Effect of very high-dose thymidine infusions on leukemia and lymphoma patientsM S Blumenreich, T M Woodcock, M Andreeff, et al.Blood|March 21, 1998
Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemiaU Consoli, I El-Tounsi, A Sandoval, et al.Leukemia|June 11, 2011
Low expression of PP2A regulatory subunit B55α is associated with T308 phosphorylation of AKT and shorter complete remission duration in acute myeloid leukemia patientsP P Ruvolo, Y H Qui, K R Coombes, et al.Leukemia|September 13, 2003
Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemiaB Z Carter, M Milella, T Tsao, et al.Science (New York, N.Y.)|October 26, 1990
Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridizationD C Tkachuk, C A Westbrook, M Andreeff, et al.Cancer Research|September 1, 1992
Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemiaS M Kornblau, H J Xu, A del Giglio, et al.Pageof 31